Amcor, a Switzerland-headquartered firm that develops and produces responsible packaging solutions, has entered into an ...
Japan headquatered Takeda's EXKIVITY (mobocertinib) has been approved by the National Medical Products Administration (N...
Primary brain cancer, though not a common malignancy, has a very poor survival rate compared to other types of cancer; m...
Aurisco, an innovative pharmaceutical company and CDMO (contract development and manufacturing organisation) in China, i...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO), has...
China-based Pulnovo Medical has announced the appointment of Dr Mingdong Zhang to the company's Scientific Advisory...
WuXi STA, a subsidiary of WuXi AppTec, has announced that its first drug product Continuous Manufacturing (CM) line for ...
Biocytogen Pharmaceuticals and Hansoh Pharmaceutical Group have announced an antibody collaboration, assignment and excl...
US-based Mission Bio and Abiosciences have announced a new partnership to co-develop bioinformatics packages for transla...
China-based GeneQuantum Healthcare (GQ) and WuXi XDC, a leading global Contract Research, Development and Manufacturing ...
On December 2nd, a nasal spray COVID-19 vaccine, VectorFlu ONE, was approved for emergency use (EU) by the national auth...
Perception Vision Medical Technologies Co., Ltd. (PVmed), a global artificial intelligence (AI) cancer treatment startup...
Merck, and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical in China), a clinical-stage biotech compa...
The Hong Kong Polytechnic University (PolyU) has joined hands with Aier Eye Hospital Group to provide six to eight weeks...
China-based XtalPi, a pioneering pharmaceutical technology startup powered by artificial intelligence (AI) and automatio...
The Chinese University of Hong Kong (CUHK) has recently hosted the naming ceremony of the Peter Hung Pain Research Insti...
A research team led by Hong Kong Baptist University (HKBU) has identified a molecular target for bone amabolic therapies...
Hong Kong headquartered Prenetics Global is acquiring a majority stake in ACT Genomics Holdings Company, an Asia&nb...
